Skip to Content Top

OVER $2.5 BILLION

OBTAINED FOR MESOTHELIOMA PATIENTS & FAMILIES
Non-small cell lung cancer
|

Researchers Seek to Develop Inhalable Treatment Option for Mesothelioma & Non-Small Cell Lung Cancer

Non-small cell lung cancer

Researchers in Japan are working to develop an inhalable powder as a new form of treatment for non-small cell lung cancer and mesothelioma. The inhalable powder is a form of gene therapy containing tumor suppression drugs SFD-p16 and SFD-p53 which contain the tumor suppressing gene p16INK4a, or p53.

The current study utilized implanted tumors in mice with significant results. Researchers observed tumor growth suppression within 24 hours after administration of the drug using luminescence imaging, on day 7 tumor volume had significantly decreased.

The researcher’s goal is to develop a noninvasive treatment option that patients will be able to self-administer.

You can read the full study on nature.com

Our Mission

  • Medical Empowerment

    Get the information you need to make informed decisions about your treatment.

  • Legal Empowerment

    Get the compensation you need to address the financial cost of your illness.

  • Going For The Gold

    Helping empower our clients with over $2.5 Billion in recoveries. We fight for our clients!

  • Giving Back To The Community

    Unprecedented Support for Mesothelioma Research. See how we can help!

Get Empowered

We put your medical and personal needs first and provide compassionate representation.
  • Please enter your first name.
  • Please enter your last name.
  • Please enter your phone number.
    This isn't a valid phone number.
  • Please enter your email address.
    This isn't a valid email address.
  • Please make a selection.
  • Please enter a message.
  • By submitting, you agree to be contacted about your request & other information using automated technology. Message frequency varies. Msg & data rates may apply. Text STOP to cancel. Acceptable Use Policy